Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: towards therapeutic management of diabetes and obesity.

Add to Collection

2022 Apr Others A Das Mahapatra, A Queen, M Yousuf… - Journal of …, 2022 - Taylor & Francis 55

Full Author : ['Das Mahapatra, Amarjyoti', 'Queen, Aarfa', 'Yousuf, Mohd', 'Khan, Parvez', 'Hussain, Afzal', 'Rehman, Md Tabish', 'Alajmi, Mohamed F', 'Datta, Bhaskar', 'Hassan, Md Imtaiyaz']
Journal Title : Journal of biomolecular structure & dynamics
Chapter : Section3
Journal Year : 2022
Cited by : 10.0

Inhibitors of carbonic anhydrase (CAIs) hold promise for addressing various diseases, including cancer, diabetes, and other metabolic syndromes. CAV is the only isoform present in the mitochondria and is considered a potential drug target for obesity. In ..... Read More

Keywords : ["human carbonic anhydrase va towards therapeutic management", "potential inhibitor", "obesity", "diabetes", "development", "design"]
PubMed Link : https://www.tandfonline.com/doi/abs/10.1080/07391102.2020.1845803
Google Scholar Link : https://scholar.google.com/scholar?cites=65608591656412001&as_sdt=5,43&sciodt=0,43&hl=en&num=20

Have a Question?

Design and development of 5-(4H)-oxazolones as potential inhibitors of human carbonic anhydrase VA: towards therapeutic management of diabetes and obesity.